Pregled bibliografske jedinice broj: 1261881
Clinical significance of TILs components in triple negative breast carcinoma
Clinical significance of TILs components in triple negative breast carcinoma // The Breast / Cardoso, Fatima (ur.).
online: Dorset Press, limited edition, 2023. str. 27-28 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1261881 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Clinical significance of TILs components in triple
negative breast carcinoma
Autori
Car Peterko, Ana ; Rajković Molek, Koraljka ; Gulić, Tamara ; Valković Zujić, Petra ; Veljković Vujaklija, Danijela ; Cini Tešar, Eleonora ; Lovasić, Franjo ; Avirović, Manuela
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
The Breast
/ Cardoso, Fatima - Online : Dorset Press, limited edition, 2023, 27-28
Skup
18th St.Gallen International Breast Cancer Conference
Mjesto i datum
Beč, Austrija, 15.03.2023. - 18.03.2023
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Triple-negative breast cancer Tumor infiltrating lymphocytes, Immunohistochemistry Prognosis
(Triple-negative breast cancer Tumor infiltrating lymphocytes, Immunohistochemistry Prognosi)
Sažetak
Goals: Tumour infiltrating lymphocytes (TILs) have recently emerged as promising new biomarkers and specific therapeutic targets in triple negative breast cancer (TNBC). However, their predictive and prognostic value is not yet fully understood. The aim of this study was the immunohistochemical (IHC) characterization of TILs in surgical biopsy specimens from TNBC patients. Methods: Clinical data and surgical tissue specimens from 68 TNBC patients who underwent the upfront surgery were included in the present analysis, as well as 36 control samples from benign breast tissue biopsies. A comprehensive IHC analysis of all significant TILs components (CD8, CD4, FOXP3, CD68 and CD11c) and immunosuppressive markers PDL-11 and CTLA4 at the invasive tumour front (ITF) and in the tumour centre (TC) was performed. Furthermore, their intercorrelations were analysed and their associations with stablished prognostic parameters and patients’ survival outcomes were tested. Results: TILs and CD8+T cell proportions are increasing toward pT2 and decreasing toward higher pT stages (P = 0.017, P = 0.21, Chi-square test). TILs density at ITF was statistically related to the expression of both CD8+ (N = 65, rho 0.56, p < 0.001, Spearman’s rank correlation) and CD4+ (N = 65, rho 0.50, p < 0.001, Spearman’s rank correlation) T cells. However, the expression of PDL-1, CTLA4 and FOXP3 was related to CD8+ T cell infiltration as well (N = 65, rho 0.31, P = 0.011 ; N = 65, rho 0.40, P < 0.001 ; N = 61, rho 0.32, P = 0.012, Spearman’s rank correlation). In the TC, TILs density was related only to the CD4+T cell infiltration (N = 65, rho 0.50, p < 0.001, Spearman’s rank correlation) and to the expression of PDL-1 and CTLA-4 (N = 66, rho 0.39, P = 0.001 ; N = 65, rho 0.46, p < 0.001, Spearman’s rank correlation). X-tile analysis was performed to determine the cut-off values, required for the TILs components’ prognostic value analysis. Following Cox regression multivariate analysis prognostic significance was confirmed for CD4 (cut-off 25%, P = 0.043, RR 2.36, HR95% 1, 03–5, 41) and PDL-1 (cut-off 5%, P < 0.001, RR 7.83, HR95% 2.32– 26.39) expression at ITF. Conclusion(s): Herein observed TILs dynamic and TILs composition suggest that commencing checkpoint inhibitors immunotherapy at the pT2 stage may be the most effective strategy. Routine determination of CD4+T cells and PDL-1 expression at the ITF may be of added value in deciding treatment escalation and de-escalation strategies in TNBC patients.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
--uniri-biomed-18-259 - Prediktivna i prognostička uloga stanica imunološkog sustava, PD-1, PDL-1 i heat shock proteina u bolesnica s trostruko negativnim, HER-2 pozitivnim i neoadjuvantno liječenim karcinomom dojke (Avirović, Manuela) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka
Profili:
Danijela Veljković Vujaklija
(autor)
Eleonora Cini Tešar
(autor)
Franjo Lovasić
(autor)
Tamara Gulić
(autor)
Manuela Avirović
(autor)
Petra Valković Zujić
(autor)
Koraljka Rajković Molek
(autor)